STAT News

STAT+: Skylark Bio kicks off new gene therapy trial for deafness

Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.

作者 STAT News

1 分钟阅读
STAT+: Skylark Bio kicks off new gene therapy trial for deafness
STAT+: Skylark Bio kicks off new gene therapy trial for deafness

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察